Fuji, Shigeo
Kurosawa, Saiko
Inamoto, Yoshihiro
Murata, Tatsunori
Utsunomiya, Atae
Uchimaru, Kaoru
Yamasaki, Satoshi
Inoue, Yoshitaka
Moriuchi, Yukiyoshi
Choi, Ilseung
Ogata, Masao http://orcid.org/0000-0002-4896-5878
Hidaka, Michihiro
Yamaguchi, Takuhiro
Fukuda, Takahiro
Article History
Received: 25 July 2017
Revised: 28 November 2017
Accepted: 16 December 2017
First Online: 25 January 2018
Compliance with ethical standards
:
: SF received honoraria from Kyowa Hakko Kirin Co., Ltd.; TM is an employee of Crecon Medical Assessment Inc, Tokyo, Japan.; AU received honoraria from Japan Blood Products Organization, Roche Diagnostics, Daiichi Sankyo, Siemens, Bristol-Myers Squibb, Pfizer, Astellas Pharma, Kyowa Hakko Kirin, Novartis Pharma, HUYA Bioscience International, Nippon Shinyaku, Chugai Pharma and Celgene, Immuno-Biological Laboratories, and Sumitomo Dainippon Pharma.; TY had ownership interests of Statcom Co., Ltd., received consulting fee from Ono Pharmaceutical Co., Ltd., received honoraria from Taiho Pharmaceutical Co., Ltd., and received research funding from Kyowa Hakko Kirin Co., Ltd.; MH received research funding from Chugai Pharm Co., Ltd. The remaining authors declare that they have no conflict of interest.